What does Zhejiang Cheng Yi Pharmaceutical Co., Ltd. do?

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 603811.SS's market cap?

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) has a market capitalization of approximately $3.41 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 603811.SS pay a dividend?

Yes — Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) pays a dividend annually, with a trailing-twelve-month yield of 4.03%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

603811.SS

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

SHH·Medical, Pharmaceuticals · Healthcare

¥7.45¥0.02+0.27%

Market cap¥3.41B·Aug 26 7:00 AM UTC

Price Chart

¥7.45+¥0.02 (+0.27%)today

+18.25%CAGR +3.41%

Select date range

FromTo

Mar 15, 2017Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)4.03%

Annual Dividend (FWD)¥0.30

Dividend Growth (5Y)+30.9%

Dividend Safety—

Payout Ratio58.0%

FCF Payout Ratio43.3%

Most Recent Dividend¥0.300

Ex-Dividend DateJun 26

Payment DateJun 26

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−6.5%

EPS Growth (3Y)+4.7%

EPS Growth (5Y)+1.3%

Next Earnings DateMay 16

Last Report DateApr 23

Reported vs Estimate¥0.14

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥827.75M

Net Income¥193.61M

Net Margin23.4%

Operating Cash Flow¥279.11M

Capital Expenditures¥59.81M

Free Cash Flow¥219.30M

Return on Equity13.3%

Return on Invested Capital2.9%

Net Cash¥230.78M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603811.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603811.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603811.SS and 80,000+ other tickers.

About Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

CEO: Chun Jian Zhao
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHH
Employees: 604
Website: www.chengyipharma.com

Peers

Peers Tab

603351.SS

Nanjing Well Pharmaceutical Group Co.,Ltd.

Cap

¥3.6B

000788.SZ

PKU HealthCare Corp.,Ltd.

Cap

¥3.4B

600568.SS

Zhongzhu Healthcare Holding Co.,Ltd

Cap

¥4.3B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603811.SS

What does Zhejiang Cheng Yi Pharmaceutical Co., Ltd. do?: Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603811.SS's market cap?: Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) has a market capitalization of approximately $3.41 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 603811.SS pay a dividend?: Yes — Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) pays a dividend annually, with a trailing-twelve-month yield of 4.03%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.